ASTRO applauds new bipartisan legislation to reform prior authorization for Medicare Advantage patients

The American Society for Radiation Oncology (ASTRO) applauded today’s introduction of bipartisan federal legislation to address critical flaws in the prior authorization process. “The prior authorization system in its current form is ineffective and harmful to patients, creating unnecessary delays to lifesaving cancer treatments and distress for the people who need them,” said Jeff M. Michalski, MD, MBA, FASTRO, Chair of the ASTRO Board of Directors.

Neurosurgeons Join Congress in Calling on CMS to Swiftly Finalize Prior Authorization Rules

Today, the American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) joined 61 bipartisan senators and 233 members of the House of Representatives in urging the U.S. Department of Health and Human Services and Centers for Medicare & Medicaid Services (CMS) to swiftly finalize rules to increase transparency, streamline and standardize prior authorization (PA), including modifying the final rules to more closely align with the Improving Seniors’ Timely Access to Care Act.

NCCN Releases Statement Addressing Ongoing Chemotherapy Shortages; Shares Survey Results Finding More than 90% of Cancer Centers are Impacted

National Comprehensive Cancer Network’s Department of Policy and Advocacy calls on Federal Government, pharmaceutical industry, providers, and payers to work together on solutions, as 93% of cancer centers surveyed report a shortage of carboplatin and 70% report shortages for cisplatin; two medications that are used in combination to cure many types of cancer.

ASTRO supports CMS’ prior authorization reform for Medicare Advantage plans

The American Society for Radiation Oncology (ASTRO) issued the following statement from Geraldine M. Jacobson, MD, MBA, MPH, FASTRO, Board of Directors Chair, in response to yesterday’s final rule from the Centers for Medicare and Medicaid Services (CMS) that revises the Medicare Advantage prior authorization process.

American College of Rheumatology: Proposed Rule Will Bring Great Transparency to Medicare Advantage Prior Authorization

The American College of Rheumatology said the Centers for Medicare and Medicaid Services’ Advancing Interoperability and Improving Prior Authorization Proposed Rule will bring greater transparency, reduce administrative burden, & make turnaround on prior authorization more predictable for payers.

AAOS to Congress: Protect Healthcare Services Before Years End

The American Association of Orthopaedic Surgeons (AAOS) is urging Congress to mitigate impending Medicare physician pay cuts and reform flawed prior authorization processes in year-end legislation.

ACR Urges the FTC to Examine the Impact of Pharmacy Benefit Managers on Prescription Drug Costs

In comments submitted to the Federal Trade Commission (FTC), the American College of Rheumatology (ACR) urged the agency to address Pharmacy Benefit Manager (PBM) business practices that drive up costs and reduce access for the 54 million Americans living with rheumatic disease.

Increased access to care and reduced treatment delays lead priorities as radiation oncologists meet with members of Congress

Radiation oncologists will meet with congressional leaders and staff today to ask for their support of policies to bolster access and equity in cancer care. Today’s American Society for Radiation Oncology (ASTRO) Advocacy Day is the first to be held in-person since the start of the COVID-19 pandemic.

Prior authorization costs radiation oncology clinics more than $40 million each year, study estimates

The time required to secure prior authorization approvals for radiation therapy treatments equates to a financial impact of more than $40 million annually for academic medical centers, according to a new study. Findings will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Benefits manager policy disrupts patient-physician decision making for breast and prostate cancer radiation treatments

Radiation oncologists today expressed serious concerns about a new private insurance coverage policy that could undermine patient-centered care for two of the most common cancers in the United States. Leaders of the American Society for Radiation Oncology (ASTRO) urge eviCore, a radiation oncology benefits management company, to halt and make meaningful changes to a new policy for radiation therapy coverage. Under the new policy, EviCore mandates that most breast and prostate cancer treatments use a shorter, hypofractionated radiation therapy regimen even if it runs counter to a physician’s clinical recommendation.

Majority of House of Representatives Supports Prior Authorization Relief Bill

Introduced by Reps. Suzan DelBene (D-Wash.), Mike Kelly (R-Pa.), Roger Marshall, MD, (R-Kan.) and Ami Bera, MD, (D-Calif.), this legislation would help protect America’s seniors from unnecessary delays in care by streamlining and standardizing prior authorization under the Medicare Advantage program, providing much-needed oversight and transparency of health insurance for America’s seniors.

ACR Releases Position Statement on Prior Authorization

The American College of Rheumatology (ACR) has released an official position statement concerning prior authorization for the approval of prescription medications, highlighting the significant burdens it creates for patients and rheumatology professionals. This process can result in a significant delay of care or treatments, treatment abandonment and potential harm to patients.